Rich Ambinder

Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection

Robin K. Avery, Ravit Arav‐Boger, Kieren A. Marr et al. · Transplantation · 2016 · 164 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

SAFETY AND EFFICACY OF COMBINATION OF BRENTUXIMAB VEDOTIN AND NIVOLUMAB IN RELAPSED / REFRACTORY HODGKIN LYMPHOMA: a TRIAL OF THE ECOG‐ACRIN CANCER RESEARCH GROUP (E4412)

Catherine Diefenbach, Fangxin Hong, Kevin A. David et al. · Hematological Oncology · 2017 · 28 citations

Pharmacy, Oncology, Pharmacotherapy +17

Post-Transplantation Cyclophosphamide after Bone Marrow Transplantation Is Not Associated with an Increased Risk of Donor-Derived Malignancy

Robbie G. Majzner, Huzefa J. Mogri, Ravi Varadhan et al. · Biology of Blood and Marrow Transplantation · 2017 · 23 citations · Full text

Medicine, Hematology, Pharmacology +13

White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab

Fayez Estephan, Xiaobu Ye, Omar Dzaye et al. · Journal of Neuro-Oncology · 2019 · 12 citations

Medicine, Neurology, Oncology +13